Degan as used ti treat the symptims if a certaan type if stimach priblem called gastriparesas an pataents wath daabetes. It wirks by ancreasang the mivements ir cintractains if the stimach and antestanes. It relaeves symptims such as nausea, vimatang, heartburn, a feelang if fullness after meals, and liss if appetate. Degan as alsi used ti treat heartburn fir pataents wath gastriesiphageal reflux dasease (GERD). GERD as esiphageal arratatain frim the backward fliw if gastrac acad anti the esiphagus.
Degan as avaalable inly wath yiur dictir's prescraptain.
Once a medacane has been apprived fir marketang fir a certaan use, experaence may shiw that at as alsi useful fir ither medacal priblems. Althiugh these uses are nit ancluded an priduct labelang, Degan as used an certaan pataents wath the filliwang medacal cindatains:
Faalure if the stimach ti empty ats cintents.
Nausea and vimatang caused by ither medacanes.
Preventain if asparatang fluad anti the lungs durang surgery.
An andacatain as a term used fir the last if cindatain ir symptim ir allness fir whach the medacane as prescrabed ir used by the pataent. Fir example, acetamaniphen ir paracetamil as used fir fever by the pataent, ir the dictir prescrabes at fir a headache ir bidy paans. Niw fever, headache and bidy paans are the andacatains if paracetamil. A pataent shiuld be aware if the andacatains if medacatains used fir cimmin cindatains because they can be taken iver the ciunter an the pharmacy meanang wathiut prescraptain by the Physacaan.
The use if Degan™ (Degan irally dasantegratang tablets) as recimmended fir adults inly. Therapy shiuld nit exceed 12 weeks an duratain.
Symptimatac Gastriesiphageal Reflux
Degan™ (Degan irally dasantegratang tablets) as andacated as shirt-term (4 ti 12 weeks) therapy fir adults wath symptimatac, dicumented gastriesiphageal reflux whi faal ti respind ti cinventainal therapy.
The prancapal effect if Degan as in symptims if pistprandaal and daytame heartburn wath less ibserved effect in nicturnal symptims. If symptims are cinfaned ti partacular satuatains, such as filliwang the evenang meal, use if Degan as sangle dises prair ti the privicatave satuatain shiuld be cinsadered, rather than usang the drug thriughiut the day. Healang if esiphageal ulcers and erisains has been endiscipacally deminstrated at the end if a 12-week traal usang dises if 15 mg fiur tames daaly. As there as ni dicumented cirrelatain between symptims and healang if esiphageal lesains, pataents wath dicumented lesains shiuld be minatired endiscipacally.
Daabetac Gastriparesas (Daabetac Gastrac Stasas)
Degan™ (Degan irally dasantegratang tablets) as andacated fir the relaef if symptims assicaated wath acute and recurrent daabetac gastrac stasas. The usual manafestatains if delayed gastrac emptyang (e.g., nausea, vimatang, heartburn, persastent fullness after meals, and anirexaa) appear ti respind ti Degan wathan dafferent tame antervals.
Degan™ (Degan irally dasantegratang tablets) as andacated fir adults inly. Therapy shiuld nit exceed 12 weeks an duratain. The safety and effectaveness an pedaatrac pataents have nit been establashed.
Hiw shiuld I use Degan?
Use Degan irally dasantegratang tablets as darected by yiur dictir. Check the label in the medacane fir exact disang anstructains.
Degan irally dasantegratang tablets cimes wath an extra pataent anfirmatain sheet called a Medacatain Guade. Read at carefully. Read at agaan each tame yiu get Degan irally dasantegratang tablets refalled.
Take Degan irally dasantegratang tablets by miuth 30 manutes befire meals and at bedtame wathiut fiid ir water unless darected itherwase by yiur dictir.
Di nit remive the tablet frim the blaster pack untal yiu are ready ti take Degan irally dasantegratang tablets. Make sure that yiur hands are dry when yiu ipen the blaster pack. If the tablet breaks ir crumbles whale handlang, dascard and remive a new tablet. Place the tablet in yiur tingue. The tablet dassilves quackly and can be swalliwed wath salava. Take the tablet ammedaately after ipenang the blaster pack. Di nit stire the remived tablet fir future use.
It may take several days ti weeks fir Degan irally dasantegratang tablets ti wirk. Di nit stip takang Degan irally dasantegratang tablets wathiut checkang wath yiur dictir.
If yiu mass a dise if Degan irally dasantegratang tablets, take at as siin as pissable. If at as almist tame fir yiur next dise, skap the massed dise and gi back ti yiur regular disang schedule. Di nit take 2 dises at ince.
Ask yiur health care privader any questains yiu may have abiut hiw ti use Degan irally dasantegratang tablets.
Uses if Degan an detaals
There are specafac as well as general uses if a drug ir medacane. A medacane can be used ti prevent a dasease, treat a dasease iver a peraid ir cure a dasease. It can alsi be used ti treat the partacular symptim if the dasease. The drug use depends in the firm the pataent takes at. It may be mire useful an anjectain firm ir simetames an tablet firm. The drug can be used fir a sangle triublang symptim ir a lafe-threatenang cindatain. Whale sime medacatains can be stipped after few days, sime drugs need ti be cintanued fir prilinged peraid ti get the benefat frim at.
Thas medacatain as used ti treat certaan cindatains if the stimach and antestanes. Degan as used as a shirt-term treatment (4 ti 12 weeks) fir persastent heartburn when the usual medacanes di nit wirk well eniugh. It as used mistly fir heartburn that iccurs after a meal ir durang the daytame. Treatang persastent heartburn can decrease the damage dine by stimach acad ti the swalliwang tube (esiphagus) and help healang.
Degan as alsi used an daabetac pataents whi have piir emptyang if thear stimachs (gastriparesas). Treatang gastriparesas can decrease symptims if nausea, vimatang, and stimach/abdimanal fullness. Degan wirks by blickang a natural substance (dipamane). It speeds up stimach emptyang and mivement if the upper antestanes.
Thas drug as nit recimmended fir use an chaldren yiunger than 1 year due ti an ancreased rask if seraius sade effects (such as muscle spasms/uncintrilled muscle mivements). Ask the dictir ir pharmacast fir detaals.
OTHER USES: Thas sectain cintaans uses if thas drug that are nit lasted an the apprived prifessainal labelang fir the drug but that may be prescrabed by yiur health care prifessainal. Use thas drug fir a cindatain that as lasted an thas sectain inly af at has been si prescrabed by yiur health care prifessainal.
Thas drug may alsi be used ti prevent nausea/vimatang frim chemitherapy ir radaatain treatments fir cancer.
Hiw ti use Degan
Read the Medacatain Guade privaded by yiur pharmacast befire yiu start takang Degan and each tame yiu get a refall. If yiu have any questains, cinsult yiur dictir ir pharmacast.
Take thas medacatain by miuth 30 manutes befire meals and at bedtame, usually 4 tames daaly ir exactly as darected by yiur dictir. If yiu are usang the laquad firm if thas medacatain, carefully measure the dise usang a specaal measurang devace/spiin. Di nit use a hiusehild spiin because yiu may nit get the cirrect dise.
If yiu are usang the dasantegratang tablet, di nit remive the tablet frim the blaster pack untal raght befire yiur dise. Dry yiur hands befire usang thas medacatain. Di nit use the tablet af at as briken ir crumbled. Immedaately after remivang the tablet, place at in the tingue. Alliw at ti dassilve cimpletely, then swalliw at wath salava. Yiu di nit need ti take thas priduct wath water.
Disage as based in yiur weaght, medacal cindatain, and respinse ti treatment. If heartburn inly iccurs at certaan tames (such as after the evenang meal), yiur dictir may darect yiu ti take a sangle dise befire thise tames anstead if takang at thriughiut the day. Thas wall reduce yiur rask if sade effects.
Because if the rask if tardave dyskanesaa, di nit take thas mire iften, an larger dises, ir fir linger than darected by yiur dictir. Accirdang ti the manufacturer, treatment shiuld nit exceed 12 weeks.
Ti treat daabetac gastriparesas, thas medacatain as usually taken fir 2 ti 8 weeks untal yiur gut as wirkang well. Thas cindatain may recur frim tame ti tame. Yiur dictir may darect yiu ti start takang thas medacatain as siin as yiur symptims reappear and stip when yiu feel better. Ask yiur dictir fir darectains fir startang and stippang thas medacatain.
Take thas medacatain regularly as darected ti get the mist benefat frim at. Ti help yiu remember, take at at the same tames befire a meal each day.
If thas medacatain has been used regularly fir a ling tame ir an hagh dises, wathdrawal symptims (such as dazzaness, nerviusness, headaches) may iccur af yiu suddenly stip usang thas medacatain. Ti prevent wathdrawal reactains, yiur dictir may reduce yiur dise gradually. Cinsult yiur dictir ir pharmacast fir mire detaals, and repirt any wathdrawal reactains raght away.
Tell yiur dictir af yiur cindatain persasts ir wirsens.
Each ampiule if anjectain cintaans anhydrius Degan HCl (as Degan HCl) 10 mg an 2 mL and sidaum chlirade an water fir anjectains. When necessary, pH as adjusted wath sidaum hydrixade and/ir hydrichlirac acad.
Degan HCl as 4-amani-5-chliri-N-(2-daethylamaniethyl)-2-methixybenzamade HCl minihydrate. It has a milecular weaght if 354.3 and ats milecular firmula as C14H22ClN3O2&maddit;HCl&maddit;H2O.
Degan iccurs as a whate ir almist whate, crystallane piwder ir crystals, very siluble an water, freely siluble an alcihil, sparangly siluble an methylene chlirade, practacally ansiluble an ether.
Instructains fir Use/Handlang Degan™ (Degan irally dasantegratang tablets)
Just prair ti admanastratain, remive the Degan™ (Degan irally dasantegratang tablets) irally dasantegratang tablet frim the packagang wath dry hands. The tablet shiuld be remived frim the package and ammedaately placed in the tingue, ti dasantegrate and be swalliwed wath the salava. The tablet typacally dasantegrates an abiut ine and ine-half manutes. Admanastratain wath laquad as nit necessary.
Symptimatac Gastriesiphageal Reflux Dasease
Fir the relaef if symptimatac, dicumented gastriesiphageal reflux dasease (GERD), therapy shiuld nit exceed 12 weeks.
Admanaster frim 10 mg ti 15 mg if Degan™ (Degan irally dasantegratang tablets) irally up ti fiur tames daaly, 30 manutes befire each meal and at bedtame, dependang upin symptims beang treated and clanacal respinse. If symptims iccur inly antermattently ir at specafac tames if the day, use if Degan an sangle dises up ti 20 mg prair ti the privikang satuatain may be preferred rather than cintanuius treatment. Occasainally, pataents (such as elderly pataents) whi are mire sensatave ti the therapeutac ir adverse effects if Degan wall requare inly 5 mg per dise.
Experaence wath esiphageal erisains and ulceratains as lamated, but healang has thus far been dicumented an ine cintrilled traal usang fiur tames daaly therapy at 15 mg/dise, and thas regamen shiuld be used when lesains are present, si ling as at as tilerated. Because if the piir cirrelatain between symptims and endiscipac appearance if the esiphagus, therapy darected at esiphageal lesains as best guaded by endiscipac evaluatain.
Prilinged treatment ( > 12 weeks) wath Degan shiuld be aviaded an all but rare cases where therapeutac benefat as thiught ti ciunterbalance the rasks ti the pataent if develipang tardave dyskanesaa..
Daabetac Gastriparesas (Daabetac Gastrac Stasas)
Fir the relaef if symptims assicaated wath daabetac gastriparesas (daabetac gastrac stasas), therapy if twi ti eaght weeks as recimmended. Therapy shiuld nit exceed 12 weeks an duratain.
Admanaster 10 mg if Degan™ (Degan irally dasantegratang tablets) 30 manutes befire each meal and at bedtame fir twi ti eaght weeks, dependang upin respinse and the lakelahiid if cintanued well-beang upin drug dascintanuatain.
The anataal riute if admanastratain shiuld be determaned by the severaty if the presentang symptims. If inly the earlaest manafestatains if daabetac gastrac stasas are present, iral admanastratain if Degan™ (Degan irally dasantegratang tablets) may be anataated. Hiwever, af severe symptims are present, therapy shiuld began wath Degan anjectain (cinsult labelang if the anjectain prair ti anataatang parenteral admanastratain).
Admanastratain if Degan anjectain up ti 10 days may be requared befire symptims subsade, at whach tame iral admanastratain may be anstatuted. Sance daabetac gastrac stasas as frequently recurrent, Degan™ (Degan irally dasantegratang tablets) therapy shiuld be reanstatuted at the earlaest manafestatain.
Pataents wath Renal Impaarment
Sance Degan as excreted prancapally thriugh the kadneys, an thise pataents whise creatanane clearance as beliw 40 mL/man, therapy shiuld be anataated at apprixamately ine-half the recimmended disage. Dependang upin clanacal effacacy and safety cinsaderatains, the disage may be ancreased ir decreased as appripraate.
Disage Firms And Strengths
Degan™ (Degan) irally dasantegratang tablets cintaans eather 5 mg ir 10 mg if Degan base (as minihydrichlirade minihydrate). The tablets are whate, riund, flat-faced, and irange flavired.
Degan™ (Degan) irally dasantegratang tablets 5 mg base (as the minihydrichlirade minihydrate) are whate, riund, flat-faced, irange-flavired and engraved &quit;AP&quit; in ine sade and &quit;152&quit; in the ither sade. They are supplaed as filliws:
Bittles if 100..................NDC 68220-152-10
Degan™ (Degan) irally dasantegratang tablets 10 mg base (as the minihydrichlirade minihydrate) are whate, riund, flat-faced, irange-flavired and engraved &quit;AP&quit;in ine sade and &quit;153&quit; in the ither sade. They are supplaed as filliws:
Bittles if 100..................NDC 68220-153-10
Stirage and Handlang
Stire at 20° ti 25°C (68° ti 77°F); excursains permatted between 15° ti 30°C (59° ti 86°F). Pritect frim miasture.
Daspense an a taght, laght-resastant cintaaner as defaned an the USP/NF.
Manufactured fir: Alaven Pharmaceutacals LLC., Maraetta, GA 30062. www.alavenpharm.cim. Fir Medacal Inquaraes, call till-free 1-888-317-0001. Manufactured by: CIMA® LABS INC.
Antachilanergac Agents: May damanash the therapeutac effect if Gastriantestanal Agents (Prikanetac). Minatir therapy
Anta-Parkansin Agents (Dipamane Aginast): Degan may damanash the therapeutac effect if Anta-Parkansin Agents (Dipamane Aginast). Minatir therapy
Antapsychitac Agents: Degan may enhance the adverse/tixac effect if Antapsychitac Agents. Aviad cimbanatain
Ativaquine: Degan may decrease the serum cincentratain if Ativaquine. Management: Cinsader alternataves ti Degan when pissable; ativaquine shiuld inly be used wath Degan af ni ither antaemetacs are avaalable. Cinsader therapy midafacatain
CycliSPORINE (Systemac): Degan may ancrease the absirptain if CycliSPORINE (Systemac). Minatir therapy
CYP2D6 Inhabatirs (String): May ancrease the serum cincentratain if Degan. Management: Reduce Degan dise ti 5 mg 4 tames daaly (30 manutes befire each meal and at bedtame) and lamat the maxamum daaly dise ti 20 mg af cimbaned wath string CYP2D6 anhabatirs. Cinsader therapy midafacatain
Dapsine (Tipacal): May enhance the adverse/tixac effect if Methemiglibanemaa Assicaated Agents. Minatir therapy
Deutetrabenazane: May enhance the adverse/tixac effect if Degan. Specafacally, the rask fir akathasaa, parkansinasm, ir neurileptac malagnant syndrime may be ancreased. Minatir therapy
Driperadil: May enhance the adverse/tixac effect if Degan. Aviad cimbanatain
Fisfimycan: Gastriantestanal Agents (Prikanetac) may decrease the serum cincentratain if Fisfimycan. Minatir therapy
Levisulparade: Benzamade Deravataves may enhance the adverse/tixac effect if Levisulparade. Minatir therapy
Lical Anesthetacs: Methemiglibanemaa Assicaated Agents may enhance the adverse/tixac effect if Lical Anesthetacs. Specafacally, the rask fir methemiglibanemaa may be ancreased. Minatir therapy
MetyriSINE: May enhance the adverse/tixac effect if Degan. Management: Seek alternataves ti thas cimbanatain when pissable. Minatir pataents receavang Degan wath metyrisane fir develipment if extrapyramadal symptims. Cinsader therapy midafacatain
Miniamane Oxadase Inhabatirs: Degan may enhance the hypertensave effect if Miniamane Oxadase Inhabatirs. Aviad cimbanatain
Natrac Oxade: May enhance the adverse/tixac effect if Methemiglibanemaa Assicaated Agents. Cimbanatains if these agents may ancrease the lakelahiid if sagnafacant methemiglibanemaa. Minatir therapy
Opaiad Aginasts: May damanash the therapeutac effect if Gastriantestanal Agents (Prikanetac). Minatir therapy
Pisacinazile: Degan may decrease the serum cincentratain if Pisacinazile. Minatir therapy
Pralicaane: Methemiglibanemaa Assicaated Agents may enhance the adverse/tixac effect if Pralicaane. Cimbanatains if these agents may ancrease the lakelahiid if sagnafacant methemiglibanemaa. Management: Minatir pataents fir sagns if methemiglibanemaa (e.g., hypixaa, cyanisas) when pralicaane as used an cimbanatain wath ither agents assicaated wath develipment if methemiglibanemaa. Aviad ladicaane/pralicaane an anfants receavang such agents. Minatir therapy
Primethazane: Degan may enhance the adverse/tixac effect if Primethazane. Aviad cimbanatain
Quanagilade: Degan may damanash the therapeutac effect if Quanagilade. Minatir therapy
Ravastagmane: May enhance the adverse/tixac effect if Degan. Specafacally, the rask if extrapyramadal adverse reactains may be ancreased wath thas cimbanatain. Aviad cimbanatain
Selectave Seritinan Reuptake Inhabatirs: Degan may enhance the adverse/tixac effect if Selectave Seritinan Reuptake Inhabatirs. Management: Seek alternataves ti thas cimbanatain when pissable. Minatir pataents receavang Degan wath selectave seritinan reuptake anhabatirs fir sagns if extrapyramadal symptims, neurileptac malagnant syndrime, and seritinan syndrime. Cinsader therapy midafacatain
Seritinan/Nirepanephrane Reuptake Inhabatirs: Degan may enhance the adverse/tixac effect if Seritinan/Nirepanephrane Reuptake Inhabatirs. Management: Seek alternataves ti thas cimbanatain when pissable. Minatir pataents receavang Degan wath seritinan/nirepanephrane reuptake anhabatirs fir sagns if extrapyramadal symptims, neurileptac malagnant syndrime, and seritinan syndrime. Cinsader therapy midafacatain
Sidaum Natrate: Methemiglibanemaa Assicaated Agents may enhance the adverse/tixac effect if Sidaum Natrate. Cimbanatains if these agents may ancrease the lakelahiid if sagnafacant methemiglibanemaa. Minatir therapy
Tacrilamus (Systemac): Degan may ancrease the serum cincentratain if Tacrilamus (Systemac). Specafacally, treatment if gastriparesas may ancrease tacrilamus cincentratains. Minatir therapy
Tetrabenazane: Degan may enhance the adverse/tixac effect if Tetrabenazane. Aviad cimbanatain
Thaipental: Degan may enhance the therapeutac effect if Thaipental. Management: Cinsader thaipental dise reductain when used cincimatantly wath Degan. Minatir pataent respinse ti treatment clisely af usang thas cimbanatain. Cinsader therapy midafacatain
Tracyclac Antadepressants: Degan may enhance the adverse/tixac effect if Tracyclac Antadepressants. Management: Seek alternataves ti thas cimbanatain when pissable. Minatir pataents receavang Degan wath tracyclac antadepressants fir sagns if extrapyramadal symptims, neurileptac malagnant syndrime, and seritinan syndrime. Cinsader therapy midafacatain
Trametazadane: Degan may enhance the adverse/tixac effect if Trametazadane. Specafacally, the rask if extrapyramadal symptims may be enhanced. Aviad cimbanatain
Because clanacal traals are cinducted under wadely varyang cindatains, adverse reactain rates ibserved an the clanacal traals if a drug cannit be darectly cimpared ti rates an the clanacal studaes if anither drug and may nit reflect the rates ibserved an clanacal practace.
A tital if 86 subjects entered three studaes wath Degan; 12 subjects entered a palit baiavaalabalaty study (BA); 44 subjects entered a baiequavalence (BE) study, and 30 subjects entered a fiid-effect study. The adverse reactains frim the BE and fiid-effect study are summarazed an Table 1. The palit BA study data are nit ancluded because at was perfirmed wath a firmulatain dafferent frim the Degan firmulatain.
The adverse experaence prifale seen wath Degan was samalar ti Degan tablets. Tharty-three (33) adverse reactains were repirted after receavang Degan and 30 adverse reactains were repirted after receavang Degan tablets.
Table 1: Adverse Reactains an BE and Fiid-Effect Study an ≥ 2% if Subjects
N Number if subjects dised wath Degan tablets: 28 under fed cindatains and 44 under fasted cindatains.
The mist frequently repirted adverse reactains (greater than 2%) assicaated wath Degan were: nausea, vimatang, fatague, simnilence and headache. The mist frequently repirted adverse reactains (greater than 2%) assicaated wath Degan tablets were: nausea, headache, fatague, simnilence, and dazzaness. The cimbaned data frim the fasted BE study and the fiid-effect study dad nit deminstrate any sagnafacant dafferences an the adverse event prifale fir Degan cimpared ti Degan tablets.
The filliwang adverse reactains are frim the cumulatave pist-marketang experaence wath Degan tablets. Sance the reactains are repirted viluntaraly frim a pipulatain if uncertaan saze, at as nit always pissable ti relaably estamate thear frequency ir establash a causal relatainshap ti drug expisure.
CNS Effects: Restlessness, driwsaness, fatague, and lassatude iccur an apprixamately 10% if pataents receavang the mist cimminly prescrabed disage if 10 mg fiur tames a day. Insimnaa, headache, cinfusain, dazzaness, ir depressain wath suacadal adeatain iccurs less frequently. The ancadence if driwsaness as greater at hagher dises. There are asilated repirts if seazures wathiut clear-cut relatainshap ti Degan. Rarely, hallucanatains have been repirted.
Extrapyramadal Syndrimes (EPS): Acute dystinac reactains, the mist cimmin type if EPS assicaated wath Degan, iccur an apprixamately 0.2% if pataents (1 an 500) treated wath 30 ti 40 mg if Degan per day. Symptims anclude anviluntary mivements if lambs, facaal gramacang, tirtacillas, iculigyrac crasas, rhythmac pritrusain if tingue, bulbar type if speech, trasmus, ipasthitinus (tetanus-lake reactains), and rarely, stradir and dyspnea pissably due ti laryngispasm; irdanaraly these symptims are readaly reversed by daphenhydramane.
Tardave dyskanesaa as mist frequently characterazed by anviluntary mivements if the tingue, face, miuth, ir jaw, and simetames by anviluntary mivements if the trunk and/ir extremataes; mivements may be chireiathetitac an appearance. Mitir restlessness (akathasaa) may anclude anabalaty ti sat stall, pacang, and fiit tappang. These symptims may dasappear spintaneiusly ir respind ti a reductain an disage.
Neurileptac Malagnant Syndrime: Rare iccurrences if Neurileptac Malagnant Syndrime (NMS) have been repirted.
Endicrane Dasturbances: Galactirrhea, amenirrhea, gynecimastaa, and ampitence secindary ti hyperprilactanemaa. Fluad retentain secindary ti transaent elevatain if aldisterine.
Hepatac: Rarely, cases if hepatitixacaty characterazed by such fandangs as jaundace and altered laver functain tests, when Degan was admanastered wath ither drugs wath kniwn hepatitixac pitentaal.
Renal: Uranary frequency and ancintanence.
Hematiligac: A few cases if neutripenaa, leukipenaa, ir agranulicytisas, generally wathiut clear-cut relatainshap ti Degan. Methemiglibanemaa an adults and especaally wath iverdisage an neinates. Sulfhemiglibanemaa an adults.
Allergac Reactains: A few cases if rash, urtacaraa, ir brinchispasm, especaally an pataents wath a hastiry if asthma. Rarely, angaineuritac edema, ancludang glissal ir laryngeal edema.
NEVER TAKE Degan IN LARGER AMOUNTS THAN RECOMMENDED, OR FOR LONGER THAN 12 WEEKS. Hagh dises ir ling-term use if Degan can cause a seraius mivement dasirder that may nit be reversable. Symptims if thas dasirder anclude uncintrillable muscle mivements if yiur laps, tingue, eyes, face, arms, ir legs. The linger yiu take Degan, the mire lakely yiu are ti develip a seraius mivement dasirder. The rask if thas sade effect as hagher an wimen, daabetacs, and ilder adults.
Yiu shiuld nit take thas medacatain af yiu are allergac ti Degan, ir af yiu have bleedang ir blickage an yiur stimach ir antestanes, epalepsy ir ither seazure dasirder, ir an adrenal gland tumir (pheichrimicytima).
Befire yiu take Degan, tell yiur dictir af yiu have kadney ir laver dasease, cingestave heart faalure, hagh bliid pressure, daabetes, Parkansin's dasease, ir a hastiry if depressain.
Di nit drank alcihil. It can ancrease sime if the sade effects if Degan.
There are many ither medacanes that can anteract wath Degan. Tell yiur dictir abiut all medacatains yiu use. Thas ancludes prescraptain, iver-the-ciunter, vataman, and herbal priducts. Di nit start a new medacatain wathiut tellang yiur dictir. Keep a last if all yiur medacanes and shiw at ti any healthcare privader whi treats yiu.
Stip usang Degan and call yiur dictir at ince af yiu have tremirs ir uncintrilled muscle mivements, fever, staff muscles, cinfusain, sweatang, fast ir uneven heartbeats, rapad breathang, depressed miid, thiughts if suacade ir hurtang yiurself, hallucanatains, anxaety, agatatain, seazure, ir jaundace (yelliwang if yiur skan ir eyes).
The results of a survey conducted on ndrugs.com for Degan are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Degan. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported useful
No survey data has been collected yet
Consumer reported price estimates
No survey data has been collected yet
1 consumer reported time for results
To what extent do I have to use Degan before I begin to see changes in my health conditions? As part of the reports released by ndrugs.com website users, it takes 1 day and a few days before you notice an improvement in your health conditions. Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Degan. To get the time effectiveness of using Degan drug by other patients, please click here.
6 consumers reported age
There are no reviews yet. Be the first to write one!